Niki BioSolutions, Inc. (NIKI) EPS (Basic) (2017 - 2025)
Niki BioSolutions' (NIKI) quarterly EPS (Basic) came in at $2.6 in Q4 2025, up 1186.38% YoY from $0.2 in Q4 2024, and up 255.07% on a QoQ basis from -$1.68 in Q3 2025.
Niki BioSolutions, Inc. (NIKI) EPS (Basic) (2017 - 2025) Analysis & Trends
Niki BioSolutions (NIKI) has 3 years of EPS (Basic) data on file, last reported at $2.6 in Q4 2025.
- Quarterly EPS (Basic) rose 1186.38% year-over-year to $2.6 in Q4 2025, while the trailing twelve-month figure through Nov 2025 was $1.45 (up 328.04% YoY) and the FY2025 annual result came in at -$2.1, down 126.85% from the prior year.
- EPS (Basic) climbed to $2.6 in Q4 2025, from -$1.68 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $2.6 in Q4 2025 to a low of -$1.68 in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2025 | 2.60 |
| Aug 31, 2025 | -1.68 |
| May 31, 2025 | 0.77 |
| Nov 30, 2024 | -0.24 |
| Aug 31, 2024 | -0.40 |
| Dec 31, 2017 | -10.81 |